Showing results (241-250 of 309) with videos related to

Sort By:
Pageof 31
The Journal of Biological Chemistry|August 5, 1991
A retinoic acid-responsive human zinc finger gene, MZF-1, preferentially expressed in myeloid cellsR Hromas, S J Collins, D Hickstein, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 30, 2024
Urinary incontinence, faecal incontinence and pelvic organ prolapse symptoms 20-26 years after childbirth: A longitudinal cohort studyS Hagen, C Sellers, A Elders, et al.
FEBS Letters|March 24, 1992
Mammalian expression of the human sex steroid-binding protein of plasma (SBP or SHBG) and testis (ABP). Characterization of the recombinant proteinF S Hagen, C Arguelles, L M Sui, et al.
Occupational and Environmental Medicine|April 16, 1998
Risks of silicosis in coalworkers exposed to unusual concentrations of respirable quartzB G Miller, S Hagen, R G Love, et al.
Orthopaedic Journal of Sports Medicine|May 6, 2024
Limited Return to Preinjury Performance in NCAA Division I American Football Players With Hamstring InjuriesWilliam M Hannay, Joseph M Sliepka, Kate Parker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2010
Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can)G Nagel, H Concin, T Bjørge, et al.
The Quarterly Journal of Medicine|May 1, 1990
Percutaneous transluminal angioplasty for atheromatous renal artery stenosis--blood pressure response and discriminant analysis of outcome predictorsF I Marshall, S Hagen, R G Mahaffy, et al.
Journal of the National Cancer Institute|February 24, 2001
Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countriesJ H Olsen, J M Hahnemann, A L Børresen-Dale, et al.
The British Journal of Dermatology|April 26, 2012
Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)G Nagel, T Bjørge, T Stocks, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2015
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumoursB Venugopal, A Awada, T R J Evans, et al.
Pageof 31